WEE1
WEE1 (WEE1 G2 checkpoint kinase, also known as WEE1A) is a nuclear tyrosine kinase that acts as a negative regulator of entry into mitosis. It phosphorylates cyclin B1-complexed CDK1 on Tyr-15, holding the G2 to M transition in check. Browse Assay Genie's current range of WEE1 research reagents below, or read on for the biology behind the target.
WEE1 acts as a negative regulator of entry into mitosis at the G2 to M transition. It protects the nucleus from cytoplasmically activated cyclin B1-complexed CDK1 before the onset of mitosis, by phosphorylating CDK1 on Tyr-15. This phosphorylation inactivates the cyclin B1-CDK1 complex. It occurs exclusively on Tyr-15 of the cyclin B1-bound kinase, and monomeric CDK1 is not phosphorylated. In this way WEE1 helps coordinate the transition between DNA replication and mitosis.
WEE1 activity is itself cell-cycle dependent. It increases during S and G2 phases, when inhibition of cyclin B1-CDK1 reaches its maximum, and decreases at M phase, when the kinase is hyperphosphorylated and CDK1 inhibition is at its minimum as cells enter mitosis. A correlated fall in WEE1 protein level at M/G1 phase is probably due to degradation. These properties make the WEE1 protein a useful readout in studies of cell cycle timing and G2 checkpoint control.
The human WEE1 gene encodes a nuclear protein that belongs to the protein kinase superfamily, in the Ser/Thr protein kinase family and WEE1 subfamily. Although classed with the Ser/Thr kinases, it catalyses inhibitory tyrosine phosphorylation, with the EC number 2.7.10.2. HGNC places it in the WEE family of tyrosine specific kinases. Earlier names reflect its origin as a homolog of the fission yeast wee1+ gene, hence 'WEE1 homolog (S. pombe)'. Mouse and rat each have a Wee1 ortholog.
WEE1 restrains cyclin B1-CDK1 through Tyr-15 phosphorylation, making it central to studies of the G2 to M transition.
By protecting the nucleus from prematurely activated CDK1, WEE1 helps coordinate DNA replication with entry into mitosis.
WEE1 is a tyrosine-specific member of the protein kinase superfamily and a model for substrate selectivity towards cyclin-bound CDK1.
WEE1 activity and protein level change across S, G2, M and G1 phases, supporting work on phosphorylation and degradation.
WEE1 negatively regulates entry into mitosis. It phosphorylates cyclin B1-complexed CDK1 on Tyr-15, inactivating the complex and protecting the nucleus from prematurely activated CDK1 during G2. Its activity peaks in S and G2 phases and falls at M phase when the kinase is hyperphosphorylated.
The approved HGNC name is WEE1 G2 checkpoint kinase, and UniProt calls the protein Wee1-like protein kinase. Alias and previous symbol WEE1A is used, and older names include wee1+ (S. pombe) homolog and WEE1 homolog (S. pombe).
Yes. The human gene has orthologs named Wee1 in both mouse and rat, and its names derive from the fission yeast wee1+ gene. Check the datasheet of any product for its validated reactivity.
Other cell cycle kinases, cyclins and G2/M checkpoint regulators with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P30291; product specifications from Assay Genie datasheets.